Levels of Evidence

Duke University's Geoffrey Ginsburg discusses the need to evaluate whether knowing patients' genetic data leads to better health care.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

The research should also

The research should also includes the cost of delivering these results.

Unless there's something

Unless there's something missing in this dialog, Dr. Ginsburg apparently hopes to evade tried and true regulatory practices for diagnostic validity. The handful of tests mentioned in his Nature articles all passed muster with the FDA or equivalent.

Sharing knowledge via Electronic Medical Records is essential, and those records may INFORM actual research and validation. However, the producers of those records (physicians) can not and should not supplant a working system.